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Abstract
Actinomycetes are saprophytic bacteria of the oral cavity. They can cause 
a rare, chronic and suppurative reaction of the teeth and mandible, and 
then involve the cervical region. We present a case of salivary gland actin-
omycosis mimicking a neoplasm. The patient underwent surgical exci-
sion and pathology confirmed the diagnosis of actinomycosis. He took 
an oral form of amoxicillin for 2 months after the operation. At the 1-year 
follow-up, there was no evidence of recurrence. Primary actinomycosis 
of the salivary gland is very rare and can mimic a neoplasm both clini-
cally and radiologically. Successful treatment relies on adequate surgical 
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Cervicofacial actinomycosis is a rare disease that is 
caused by an inhabitant of the normal oral flora [1]. 
It can be found as a saprophyte in the oral cavity and 
has not been isolated in vitro [2]. Actinomycosis was 
first reported in humans by Von Lanfenbeck in 1845 
and was thought to be a fungus. Waksman showed that 
Actinomyces was an anaerobic Gram-positive bacte-
rium in the 1960s [3]. Five species of Actinomyces
have been identified, and the most common in hu-
mans is Actinomyces israelii [1,3].
Most major medical centers report an average of 
one actinomycosis case per year [2]. The incidence of 
actinomycosis in all submitted specimens ranges from 
0.1% [4] to 0.37% [5]. There is a male predominance 
(ranging from 1.5:1 to 3:1) reported in many series 
and the fifth decade of life is the most affected [2,3]. 
The clinical symptoms depend on the location of the 
disease. The common locations of actinomycosis are: 
cervicofacial (40–60%), abdominopelvic (20%), tho-
racic (15%) and central nervous system (2%) [1]. The 
facial skeleton is often affected [1].
The main causes of actinomycosis include dental 
infection, manipulations and oromaxillofacial trauma 
[1–3]. Disease occurs almost exclusively by direct 
invasion, and rarely by metastatic or hematogenous 
spread [2]. An immunosuppressed state, diabetes 
and malignancy are predisposing factors [1–3,6]. 
The clinical manifestations include two forms: one is 
chronic, progressive and indolent with indurated in-
filtration, and multiple abscess and fistulas; the other 
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is more acute and rapidly progressive, with fever and 
a sore, fluctuating swelling that cause it to resemble 
a typical pyogenic infection [1].
Imaging studies, such as computed tomography 
(CT) or magnetic resonance imaging (MRI), help to 
define the extent of the disease. Definite diagnosis 
relies on positive cultures and biopsy showing the 
bacteria. The propensity of this disease to mimic car-
cinoma or tuberculosis is well known [1–3,6–9]. Chiang 
et al [7] reported a nasopharyngeal actinomycosis case 
imitating nasopharyngeal carcinoma. It must be con-
sidered as the great masquerader of head and neck 
disease [2].
2. Case report
A 62-year-old male patient visited our Ear, Nose and 
Throat (ENT) Outpatient Department with a history of 
right submandibular swelling for about 10 years. The 
mass had enlarged rapidly in recent days. Examination 
of the head and neck showed a firm, fixed and tender 
mass over the right submandibular area. The size of 
the mass was 3 ˜  3 cm, and did not fluctuate in size 
after eating. The patient also had Addison’s disease 
that had been treated with cortisone for 3 years, and 
his oral hygiene was poor.
Imaging study (CT scan with contrast medium en-
hancement) was performed and showed a 3 ˜  3 cm 
heterogeneous mass over the right submandibular 
area (Fig. 1). Laboratory studies, including complete 
blood count and biochemistry profile, were all within 
normal limits. The patient underwent surgical exci-
sion and pathology revealed Actinomyces flora with 
sulfur granules on hematoxylin and eosin staining 
(Fig. 2). After the operation, the patient was prescribed 
an oral form of amoxicillin 500 mg to be taken 3 times 
daily for 2 months. At the 1-year follow- up, the patient 
was healthy and there was no sign of recurrence.
3. Discussion
Actinomycosis is a chronic and suppurative infection 
that can occur in the head and neck region. Initial pre-
sentation is usually a palpable mass and it is some-
times accompanied by surrounding skin erythematous 
changes. The clinical diagnosis is difficult to estab-
lish because the onset and duration of the disease 
are not specific, and the differential diagnosis should 
cover a wide range of diseases from tumor to chronic 
infections such as tuberculosis [3].
The imaging modalities cited in the literature are CT, 
sialography, radionuclide imaging, ultrasonography 
(US) and MRI [1]. CT is more effective at defining the 
extent of the abscess and the surrounding anatomical 
structures [1]. Usually, actinomycosis appears as an ill-
defined soft tissue mass with rim enhancement on CT, 
and the radiological differential diagnoses include 
branchial cleft cyst, lymph node metastasis, inflamma-
tory lymphadenopathy and vascular tumor [3]. MRI is 
sometimes helpful in defining the relation between the 
inflammatory process and cervical soft tissues [3].
Actinomyces is noted for forming characteristic 
sulfur granules in infected tissue but not in vitro
[2,3,8,9]. The term sulfur granule has been a mis-
nomer for a long time; the name actually reflects the 
yellow color of the granules in pus as the granules 
Fig. 1 — Neck computed tomography with contrast medium 
enhancement shows a heterogeneous mass (arrow) over 
the right submandibular region.
Fig. 2 — Actinomyces (arrowhead) and sulfur granules 
(arrow) (hematoxylin & eosin, 400´). A large ball-like 
cluster of Actinomyces with filaments or sulfur granules 
(located at the edges) and aggregates (central location) 
in a background of acute inflammation.
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contain no sulfur at all [2]. They are composed of an 
internal tangle of mycelial fragments and a rosette of 
peripheral clubs. In our case, we saw the typical find-
ings of Actinomyces and sulfur granules with hema-
toxylin and eosin staining (Fig. 2).
Definite diagnosis of actinomycosis relies on posi-
tive cultures and histopathology [2,3]. Therefore, fine 
needle aspiration cytology or open biopsy for pathology 
should be performed to make the diagnosis.
Since the advent of antibiotic therapy, the princi-
ples for management of cervicofacial actinomycosis 
have emphasized a prolonged treatment schedule 
coupled with surgical management if necessary. High-
dose penicillin remains the treatment of choice [2]. 
A 2-month course of oral penicillin V, 2–4 g/day in 
four divided doses, or oral amoxicillin, 500 mg three 
times daily, are equally efficacious [2]. Surgical inter-
vention is recommended for excision of necrotic tis-
sue and curettage of affected bony tissue [10]. The 
duration of therapy should be related to the severity 
of the disease and ongoing assessment for clinical or 
pathological remission. Intensive, prolonged penicillin 
therapy (12–18 months) and surgery were described 
by Harvey et al in 1957 [11]. Alternatives to penicil-
lin include doxycycline, ceftriaxone, clindamycin, 
erythromycin and chloramphenicol [12].
There are no specific methods to prevent cervicofa-
cial actinomycosis. Maintenance of good oral hygiene 
and appropriate plaque removal can limit the tendency 
of Actinomyces to establish dense colonization and 
subclinical infection.
Actinomycosis should be considered when patients 
present with cervicofacial swelling.
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